HU220777B1 - Több anyag szimultán elemzésére szolgáló eszközök és berendezések - Google Patents
Több anyag szimultán elemzésére szolgáló eszközök és berendezések Download PDFInfo
- Publication number
- HU220777B1 HU220777B1 HU9800920A HUP9800920A HU220777B1 HU 220777 B1 HU220777 B1 HU 220777B1 HU 9800920 A HU9800920 A HU 9800920A HU P9800920 A HUP9800920 A HU P9800920A HU 220777 B1 HU220777 B1 HU 220777B1
- Authority
- HU
- Hungary
- Prior art keywords
- ligands
- reaction
- analyte
- carrier
- biological
- Prior art date
Links
- 238000001514 detection method Methods 0.000 title description 21
- 239000003446 ligand Substances 0.000 claims description 56
- 238000000034 method Methods 0.000 claims description 46
- 239000000919 ceramic Substances 0.000 claims description 34
- 229920001296 polysiloxane Polymers 0.000 claims description 29
- 238000012360 testing method Methods 0.000 claims description 29
- 238000006243 chemical reaction Methods 0.000 claims description 28
- 239000000126 substance Substances 0.000 claims description 24
- 238000003556 assay Methods 0.000 claims description 23
- 239000003153 chemical reaction reagent Substances 0.000 claims description 23
- 239000012491 analyte Substances 0.000 claims description 21
- 239000002245 particle Substances 0.000 claims description 20
- 230000008569 process Effects 0.000 claims description 17
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims description 16
- 229910000077 silane Inorganic materials 0.000 claims description 16
- 230000001588 bifunctional effect Effects 0.000 claims description 14
- 230000003993 interaction Effects 0.000 claims description 14
- 238000004458 analytical method Methods 0.000 claims description 13
- 239000004816 latex Substances 0.000 claims description 10
- 229920000126 latex Polymers 0.000 claims description 10
- 229940088597 hormone Drugs 0.000 claims description 9
- 239000005556 hormone Substances 0.000 claims description 9
- 239000004971 Cross linker Substances 0.000 claims description 8
- 102000004190 Enzymes Human genes 0.000 claims description 7
- 108090000790 Enzymes Proteins 0.000 claims description 7
- 230000000269 nucleophilic effect Effects 0.000 claims description 7
- 239000003242 anti bacterial agent Substances 0.000 claims description 6
- 229940088710 antibiotic agent Drugs 0.000 claims description 6
- 239000000412 dendrimer Substances 0.000 claims description 6
- 229920000736 dendritic polymer Polymers 0.000 claims description 6
- 125000000524 functional group Chemical group 0.000 claims description 6
- 239000011521 glass Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 230000000903 blocking effect Effects 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 229920001223 polyethylene glycol Polymers 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 238000013519 translation Methods 0.000 claims description 5
- 230000003100 immobilizing effect Effects 0.000 claims description 4
- 210000002700 urine Anatomy 0.000 claims description 4
- 206010020751 Hypersensitivity Diseases 0.000 claims description 3
- 208000026935 allergic disease Diseases 0.000 claims description 3
- 230000007815 allergy Effects 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000010453 quartz Substances 0.000 claims description 3
- 210000002966 serum Anatomy 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 208000013875 Heart injury Diseases 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 239000004793 Polystyrene Substances 0.000 claims description 2
- 241000700605 Viruses Species 0.000 claims description 2
- 230000003213 activating effect Effects 0.000 claims description 2
- 210000000941 bile Anatomy 0.000 claims description 2
- 210000003608 fece Anatomy 0.000 claims description 2
- 235000013305 food Nutrition 0.000 claims description 2
- 239000002773 nucleotide Substances 0.000 claims description 2
- 125000003729 nucleotide group Chemical group 0.000 claims description 2
- 210000002381 plasma Anatomy 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 229920002521 macromolecule Polymers 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 125000000837 carbohydrate group Chemical group 0.000 claims 1
- 239000012876 carrier material Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 230000002458 infectious effect Effects 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- 238000012545 processing Methods 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
- 229940124530 sulfonamide Drugs 0.000 description 37
- 150000003456 sulfonamides Chemical class 0.000 description 35
- 239000000758 substrate Substances 0.000 description 33
- 239000000523 sample Substances 0.000 description 25
- 230000027455 binding Effects 0.000 description 20
- -1 aryl azides Chemical class 0.000 description 14
- 239000011230 binding agent Substances 0.000 description 13
- 239000000463 material Substances 0.000 description 11
- 102000003946 Prolactin Human genes 0.000 description 10
- 108010057464 Prolactin Proteins 0.000 description 10
- 229940097325 prolactin Drugs 0.000 description 10
- 150000004756 silanes Chemical class 0.000 description 10
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 9
- 239000000969 carrier Substances 0.000 description 8
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 7
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 7
- 229940028334 follicle stimulating hormone Drugs 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 230000009871 nonspecific binding Effects 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 230000004913 activation Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 229960002135 sulfadimidine Drugs 0.000 description 6
- 229960002597 sulfamerazine Drugs 0.000 description 6
- PJSFRIWCGOHTNF-UHFFFAOYSA-N Sulphormetoxin Chemical compound COC1=NC=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1OC PJSFRIWCGOHTNF-UHFFFAOYSA-N 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical group O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- 229950008831 sulfachlorpyridazine Drugs 0.000 description 5
- 229960000973 sulfadimethoxine Drugs 0.000 description 5
- ZZORFUFYDOWNEF-UHFFFAOYSA-N sulfadimethoxine Chemical compound COC1=NC(OC)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 ZZORFUFYDOWNEF-UHFFFAOYSA-N 0.000 description 5
- 229960004673 sulfadoxine Drugs 0.000 description 5
- QPPBRPIAZZHUNT-UHFFFAOYSA-N sulfamerazine Chemical compound CC1=CC=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 QPPBRPIAZZHUNT-UHFFFAOYSA-N 0.000 description 5
- ASWVTGNCAZCNNR-UHFFFAOYSA-N sulfamethazine Chemical compound CC1=CC(C)=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 ASWVTGNCAZCNNR-UHFFFAOYSA-N 0.000 description 5
- 229960005158 sulfamethizole Drugs 0.000 description 5
- 229960001544 sulfathiazole Drugs 0.000 description 5
- NHZLNPMOSADWGC-UHFFFAOYSA-N 4-amino-N-(2-quinoxalinyl)benzenesulfonamide Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=CN=C(C=CC=C2)C2=N1 NHZLNPMOSADWGC-UHFFFAOYSA-N 0.000 description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 4
- 239000012965 benzophenone Substances 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 238000003018 immunoassay Methods 0.000 description 4
- XOXHILFPRYWFOD-UHFFFAOYSA-N sulfachloropyridazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=CC=C(Cl)N=N1 XOXHILFPRYWFOD-UHFFFAOYSA-N 0.000 description 4
- VACCAVUAMIDAGB-UHFFFAOYSA-N sulfamethizole Chemical compound S1C(C)=NN=C1NS(=O)(=O)C1=CC=C(N)C=C1 VACCAVUAMIDAGB-UHFFFAOYSA-N 0.000 description 4
- 229960005404 sulfamethoxazole Drugs 0.000 description 4
- JNMRHUJNCSQMMB-UHFFFAOYSA-N sulfathiazole Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CS1 JNMRHUJNCSQMMB-UHFFFAOYSA-N 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- UVGHPGOONBRLCX-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 6-[5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoylamino]hexanoate Chemical compound S1CC2NC(=O)NC2C1CCCCC(=O)NCCCCCC(=O)ON1C(=O)CCC1=O UVGHPGOONBRLCX-UHFFFAOYSA-N 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 3
- 239000004593 Epoxy Substances 0.000 description 3
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 3
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 3
- 239000002876 beta blocker Substances 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 125000003636 chemical group Chemical group 0.000 description 3
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000001917 fluorescence detection Methods 0.000 description 3
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 230000001592 luteinising effect Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- GOUHYARYYWKXHS-UHFFFAOYSA-N 4-formylbenzoic acid Chemical compound OC(=O)C1=CC=C(C=O)C=C1 GOUHYARYYWKXHS-UHFFFAOYSA-N 0.000 description 2
- 102000011632 Caseins Human genes 0.000 description 2
- 108010076119 Caseins Proteins 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 208000033962 Fontaine progeroid syndrome Diseases 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical class ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 238000005411 Van der Waals force Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229940126575 aminoglycoside Drugs 0.000 description 2
- 239000003263 anabolic agent Substances 0.000 description 2
- 229940070021 anabolic steroids Drugs 0.000 description 2
- 239000012131 assay buffer Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 229910010293 ceramic material Inorganic materials 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- 238000005370 electroosmosis Methods 0.000 description 2
- 125000003700 epoxy group Chemical group 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 150000002960 penicillins Chemical class 0.000 description 2
- 238000000206 photolithography Methods 0.000 description 2
- 229920002120 photoresistant polymer Polymers 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000002444 silanisation Methods 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- 238000000527 sonication Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 229940040944 tetracyclines Drugs 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- RBKHNGHPZZZJCI-UHFFFAOYSA-N (4-aminophenyl)-phenylmethanone Chemical compound C1=CC(N)=CC=C1C(=O)C1=CC=CC=C1 RBKHNGHPZZZJCI-UHFFFAOYSA-N 0.000 description 1
- QBLFZIBJXUQVRF-UHFFFAOYSA-N (4-bromophenyl)boronic acid Chemical compound OB(O)C1=CC=C(Br)C=C1 QBLFZIBJXUQVRF-UHFFFAOYSA-N 0.000 description 1
- NRESDXFFSNBDGP-UHFFFAOYSA-N (4-bromophenyl)hydrazine Chemical compound NNC1=CC=C(Br)C=C1 NRESDXFFSNBDGP-UHFFFAOYSA-N 0.000 description 1
- SWJPEBQEEAHIGZ-UHFFFAOYSA-N 1,4-dibromobenzene Chemical compound BrC1=CC=C(Br)C=C1 SWJPEBQEEAHIGZ-UHFFFAOYSA-N 0.000 description 1
- LFMWZTSOMGDDJU-UHFFFAOYSA-N 1,4-diiodobenzene Chemical compound IC1=CC=C(I)C=C1 LFMWZTSOMGDDJU-UHFFFAOYSA-N 0.000 description 1
- GVJXGCIPWAVXJP-UHFFFAOYSA-N 2,5-dioxo-1-oxoniopyrrolidine-3-sulfonate Chemical compound ON1C(=O)CC(S(O)(=O)=O)C1=O GVJXGCIPWAVXJP-UHFFFAOYSA-N 0.000 description 1
- PFDBEACWLCHWRZ-UHFFFAOYSA-N 2-(4-bromophenyl)propanoic acid Chemical compound OC(=O)C(C)C1=CC=C(Br)C=C1 PFDBEACWLCHWRZ-UHFFFAOYSA-N 0.000 description 1
- UJJMLGJZQGGQAZ-UHFFFAOYSA-N 2-(fluoromethyl)pyridine Chemical compound FCC1=CC=CC=N1 UJJMLGJZQGGQAZ-UHFFFAOYSA-N 0.000 description 1
- DYNFCHNNOHNJFG-UHFFFAOYSA-N 2-formylbenzoic acid Chemical compound OC(=O)C1=CC=CC=C1C=O DYNFCHNNOHNJFG-UHFFFAOYSA-N 0.000 description 1
- 125000003852 3-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(Cl)=C1[H])C([H])([H])* 0.000 description 1
- BKMRWJWLBHHGCF-UHFFFAOYSA-N 4-(2-bromoethyl)benzoic acid Chemical compound OC(=O)C1=CC=C(CCBr)C=C1 BKMRWJWLBHHGCF-UHFFFAOYSA-N 0.000 description 1
- CQQSQBRPAJSTFB-UHFFFAOYSA-N 4-(bromomethyl)benzoic acid Chemical compound OC(=O)C1=CC=C(CBr)C=C1 CQQSQBRPAJSTFB-UHFFFAOYSA-N 0.000 description 1
- GIQCYNIPMFKRLR-UHFFFAOYSA-N 4-(dimethylamino)-1h-pyridin-2-one Chemical compound CN(C)C=1C=CNC(=O)C=1 GIQCYNIPMFKRLR-UHFFFAOYSA-N 0.000 description 1
- WWYFPDXEIFBNKE-UHFFFAOYSA-N 4-(hydroxymethyl)benzoic acid Chemical compound OCC1=CC=C(C(O)=O)C=C1 WWYFPDXEIFBNKE-UHFFFAOYSA-N 0.000 description 1
- QOWSWEBLNVACCL-UHFFFAOYSA-N 4-Bromophenyl acetate Chemical compound OC(=O)CC1=CC=C(Br)C=C1 QOWSWEBLNVACCL-UHFFFAOYSA-N 0.000 description 1
- PQXPAFTXDVNANI-UHFFFAOYSA-N 4-azidobenzoic acid Chemical compound OC(=O)C1=CC=C(N=[N+]=[N-])C=C1 PQXPAFTXDVNANI-UHFFFAOYSA-N 0.000 description 1
- WDFQBORIUYODSI-UHFFFAOYSA-N 4-bromoaniline Chemical compound NC1=CC=C(Br)C=C1 WDFQBORIUYODSI-UHFFFAOYSA-N 0.000 description 1
- ZRYZBQLXDKPBDU-UHFFFAOYSA-N 4-bromobenzaldehyde Chemical compound BrC1=CC=C(C=O)C=C1 ZRYZBQLXDKPBDU-UHFFFAOYSA-N 0.000 description 1
- TUXYZHVUPGXXQG-UHFFFAOYSA-N 4-bromobenzoic acid Chemical compound OC(=O)C1=CC=C(Br)C=C1 TUXYZHVUPGXXQG-UHFFFAOYSA-N 0.000 description 1
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 1
- SKDHHIUENRGTHK-UHFFFAOYSA-N 4-nitrobenzoyl chloride Chemical compound [O-][N+](=O)C1=CC=C(C(Cl)=O)C=C1 SKDHHIUENRGTHK-UHFFFAOYSA-N 0.000 description 1
- BRLRJZRHRJEWJY-VCOUNFBDSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-n-[3-[3-(4-azido-2-nitroanilino)propyl-methylamino]propyl]pentanamide Chemical compound C([C@H]1[C@H]2NC(=O)N[C@H]2CS1)CCCC(=O)NCCCN(C)CCCNC1=CC=C(N=[N+]=[N-])C=C1[N+]([O-])=O BRLRJZRHRJEWJY-VCOUNFBDSA-N 0.000 description 1
- CMUGHZFPFWNUQT-HUBLWGQQSA-N 6-[5-(2-oxo-hexahydro-thieno[3,4-d]imidazol-4-yl)-pentanoylamino]-hexanoic acid Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)NCCCCCC(=O)O)SC[C@@H]21 CMUGHZFPFWNUQT-HUBLWGQQSA-N 0.000 description 1
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 102000004420 Creatine Kinase Human genes 0.000 description 1
- 108010042126 Creatine kinase Proteins 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- 102000030914 Fatty Acid-Binding Human genes 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 102000007390 Glycogen Phosphorylase Human genes 0.000 description 1
- 108010046163 Glycogen Phosphorylase Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 229920002556 Polyethylene Glycol 300 Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229940123317 Sulfonamide antibiotic Drugs 0.000 description 1
- 102000011923 Thyrotropin Human genes 0.000 description 1
- 108010061174 Thyrotropin Proteins 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 102000013394 Troponin I Human genes 0.000 description 1
- 108010065729 Troponin I Proteins 0.000 description 1
- 102000004987 Troponin T Human genes 0.000 description 1
- 108090001108 Troponin T Proteins 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000007818 agglutination assay Methods 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- 125000004057 biotinyl group Chemical class [H]N1C(=O)N([H])[C@]2([H])[C@@]([H])(SC([H])([H])[C@]12[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000007767 bonding agent Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000005081 chemiluminescent agent Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000002967 competitive immunoassay Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- MGNCLNQXLYJVJD-UHFFFAOYSA-N cyanuric chloride Chemical compound ClC1=NC(Cl)=NC(Cl)=N1 MGNCLNQXLYJVJD-UHFFFAOYSA-N 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- UWGIJJRGSGDBFJ-UHFFFAOYSA-N dichloromethylsilane Chemical compound [SiH3]C(Cl)Cl UWGIJJRGSGDBFJ-UHFFFAOYSA-N 0.000 description 1
- FFYPMLJYZAEMQB-UHFFFAOYSA-N diethyl pyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- QFTYSVGGYOXFRQ-UHFFFAOYSA-N dodecane-1,12-diamine Chemical compound NCCCCCCCCCCCCN QFTYSVGGYOXFRQ-UHFFFAOYSA-N 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 229920006332 epoxy adhesive Polymers 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 108091022862 fatty acid binding Proteins 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000001030 gas--liquid chromatography Methods 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- LFKYBJLFJOOKAE-UHFFFAOYSA-N imidazol-2-ylidenemethanone Chemical compound O=C=C1N=CC=N1 LFKYBJLFJOOKAE-UHFFFAOYSA-N 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002555 ionophore Substances 0.000 description 1
- 230000000236 ionophoric effect Effects 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- JMZFEHDNIAQMNB-UHFFFAOYSA-N m-aminophenylboronic acid Chemical compound NC1=CC=CC(B(O)O)=C1 JMZFEHDNIAQMNB-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- NWLSIXHRLQYIAE-UHFFFAOYSA-N oxiran-2-ylmethoxysilicon Chemical compound [Si]OCC1CO1 NWLSIXHRLQYIAE-UHFFFAOYSA-N 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 1
- 230000036211 photosensitivity Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000012048 reactive intermediate Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004306 sulfadiazine Drugs 0.000 description 1
- 229960004936 sulfamethoxypyridazine Drugs 0.000 description 1
- VLYWMPOKSSWJAL-UHFFFAOYSA-N sulfamethoxypyridazine Chemical compound N1=NC(OC)=CC=C1NS(=O)(=O)C1=CC=C(N)C=C1 VLYWMPOKSSWJAL-UHFFFAOYSA-N 0.000 description 1
- 229960002211 sulfapyridine Drugs 0.000 description 1
- GECHUMIMRBOMGK-UHFFFAOYSA-N sulfapyridine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=CC=CC=N1 GECHUMIMRBOMGK-UHFFFAOYSA-N 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- KUCOHFSKRZZVRO-UHFFFAOYSA-N terephthalaldehyde Chemical compound O=CC1=CC=C(C=O)C=C1 KUCOHFSKRZZVRO-UHFFFAOYSA-N 0.000 description 1
- LXEJRKJRKIFVNY-UHFFFAOYSA-N terephthaloyl chloride Chemical compound ClC(=O)C1=CC=C(C(Cl)=O)C=C1 LXEJRKJRKIFVNY-UHFFFAOYSA-N 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- ZWZVWGITAAIFPS-UHFFFAOYSA-N thiophosgene Chemical compound ClC(Cl)=S ZWZVWGITAAIFPS-UHFFFAOYSA-N 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 125000005490 tosylate group Chemical group 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
- G01N33/552—Glass or silica
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/924—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis using nanostructure as support of dna analysis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97302707 | 1997-04-21 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU9800920D0 HU9800920D0 (en) | 1998-06-29 |
| HUP9800920A1 HUP9800920A1 (hu) | 1998-10-28 |
| HU220777B1 true HU220777B1 (hu) | 2002-05-28 |
Family
ID=8229307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9800920A HU220777B1 (hu) | 1997-04-21 | 1998-04-20 | Több anyag szimultán elemzésére szolgáló eszközök és berendezések |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US6498010B1 (sk) |
| JP (1) | JP4209494B2 (sk) |
| KR (1) | KR100585548B1 (sk) |
| CN (1) | CN1178063C (sk) |
| AR (1) | AR015110A1 (sk) |
| AT (1) | ATE289684T1 (sk) |
| AU (1) | AU713388B2 (sk) |
| BR (1) | BR9800655A (sk) |
| CA (1) | CA2235183C (sk) |
| CZ (1) | CZ297165B6 (sk) |
| DE (1) | DE69829089T3 (sk) |
| EG (1) | EG22471A (sk) |
| ES (1) | ES2238750T5 (sk) |
| GB (1) | GB2324866B (sk) |
| GE (1) | GEP20022846B (sk) |
| HK (1) | HK1012202A1 (sk) |
| HR (1) | HRP980215A2 (sk) |
| HU (1) | HU220777B1 (sk) |
| ID (1) | ID20179A (sk) |
| MY (1) | MY114814A (sk) |
| NO (1) | NO981766L (sk) |
| NZ (1) | NZ330227A (sk) |
| PL (1) | PL325914A1 (sk) |
| PT (1) | PT874242E (sk) |
| RU (1) | RU2168174C2 (sk) |
| SG (1) | SG87765A1 (sk) |
| SK (1) | SK283340B6 (sk) |
| TR (1) | TR199800737A1 (sk) |
| TW (1) | TWI225928B (sk) |
| UA (1) | UA54400C2 (sk) |
| YU (1) | YU49328B (sk) |
| ZA (1) | ZA983345B (sk) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020157526A1 (en) | 2019-01-28 | 2020-08-06 | Ioi Auranae Kft | Device and method for the automatic determination of anion and cation levels from urine |
Families Citing this family (76)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9800655A (pt) * | 1997-04-21 | 1999-08-10 | Randox Lab Ltd | Dispositivo de estado sólido para efetuar ensaios com múltiplos analisados seu uso e e sistema para análise de múltiplos analisados |
| US20060029926A1 (en) * | 1998-05-06 | 2006-02-09 | Metrika, Inc. | Blocking compositions for immunoassays |
| JP4261661B2 (ja) * | 1999-01-28 | 2009-04-30 | キヤノン株式会社 | プローブ結合基板、プローブ結合基板の製造方法、プローブアレイ、標的物質の検出方法、サンプル中の一本鎖核酸の塩基配列を特定する方法、及びサンプル中の標的物質の定量方法 |
| US6326083B1 (en) * | 1999-03-08 | 2001-12-04 | Calipher Technologies Corp. | Surface coating for microfluidic devices that incorporate a biopolymer resistant moiety |
| JP4536304B2 (ja) * | 1999-07-14 | 2010-09-01 | スペクトラル ダイアグノスティックス インコーポレイテッド | 診断試験用球体の調製 |
| AUPR005600A0 (en) * | 2000-09-12 | 2000-10-05 | University Of Sydney, The | Diagnostic assay |
| GB0027064D0 (en) * | 2000-11-06 | 2000-12-20 | Randox Lab Ltd | Multi-analyte immunoassay |
| US6649078B2 (en) * | 2000-12-06 | 2003-11-18 | The Regents Of The University Of California | Thin film capillary process and apparatus |
| GB0102357D0 (en) * | 2001-01-30 | 2001-03-14 | Randox Lab Ltd | Imaging method |
| AU2002322458A1 (en) | 2001-07-13 | 2003-01-29 | Nanosphere, Inc. | Method for immobilizing molecules onto surfaces |
| GB0120202D0 (en) | 2001-08-18 | 2001-10-10 | Psimedica | Body fluid collection and analysis |
| US7097882B2 (en) * | 2001-08-21 | 2006-08-29 | Samsung Sdi Co., Ltd. | Substrate for immobilizing physiological material, and method of fabricating same |
| GB0124338D0 (en) * | 2001-10-10 | 2001-11-28 | Randox Lab Ltd | Biochips |
| US6780602B2 (en) * | 2001-11-01 | 2004-08-24 | Microbiosystems, Limited Partnership | Taxonomic identification of pathogenic microorganisms and their toxic proteins |
| KR100450191B1 (ko) * | 2001-12-28 | 2004-10-02 | 삼성에스디아이 주식회사 | 생체물질 고정용 기판 및 이의 제조방법 |
| US20050158848A1 (en) * | 2002-04-12 | 2005-07-21 | Ulrich Sieben | Method for immobolizing molecules on surfaces |
| US20030208936A1 (en) * | 2002-05-09 | 2003-11-13 | Lee Charles Hee | Method for manufacturing embroidery decorated cards and envelopes |
| US20040115830A1 (en) * | 2002-09-25 | 2004-06-17 | Igor Touzov | Components for nano-scale Reactor |
| US7070922B2 (en) | 2002-12-04 | 2006-07-04 | International Business Machines Corporation | Surface treatment |
| US20040129676A1 (en) * | 2003-01-07 | 2004-07-08 | Tan Roy H. | Apparatus for transfer of an array of liquids and methods for manufacturing same |
| US6972148B2 (en) | 2003-06-23 | 2005-12-06 | Kimberly-Clark Worldwide, Inc. | Glove having improved donning characteristics |
| US7695688B2 (en) * | 2003-09-19 | 2010-04-13 | Applied Biosystems, Llc | High density plate filler |
| US7407630B2 (en) | 2003-09-19 | 2008-08-05 | Applera Corporation | High density plate filler |
| US7998435B2 (en) | 2003-09-19 | 2011-08-16 | Life Technologies Corporation | High density plate filler |
| US8277760B2 (en) | 2003-09-19 | 2012-10-02 | Applied Biosystems, Llc | High density plate filler |
| US9492820B2 (en) | 2003-09-19 | 2016-11-15 | Applied Biosystems, Llc | High density plate filler |
| EP1682261B1 (en) | 2003-11-12 | 2012-08-15 | BIO-RAD Haifa Ltd. | Method for carrying out multiple binding reactions in an array format |
| DE60321244D1 (de) * | 2003-12-31 | 2008-07-03 | Council Scient Ind Res | Verfahren und vorrichtung zur analyse von pestiziden |
| US20090010819A1 (en) * | 2004-01-17 | 2009-01-08 | Gyros Patent Ab | Versatile flow path |
| US8592219B2 (en) | 2005-01-17 | 2013-11-26 | Gyros Patent Ab | Protecting agent |
| EP1718973B1 (en) * | 2004-02-09 | 2009-09-09 | Rapid Pathogen Screening Inc. | Method for the rapid diagnosis of targets in human body fluids |
| US20140031249A1 (en) * | 2004-07-20 | 2014-01-30 | Sqi Diagnostics Systems Inc. | Multiplex measure of isotype antigen response |
| US7229782B1 (en) | 2004-08-03 | 2007-06-12 | Labone, Inc. | Antibodies specific to multiple beta blockers and methods for their use |
| EP1657235B1 (en) | 2004-11-10 | 2011-09-21 | Randox Laboratories Ltd. | Phenethanolamine-derived haptens, immunogens and conjugates comprising them and antibodies recognising said immunogenes and conjugates |
| FR2879483B1 (fr) * | 2004-12-20 | 2007-04-27 | Commissariat Energie Atomique | Procede pour augmenter l'hydrophobicite d'un revetement externe d'un dispositif d'analyse, tel qu'une biopuce, un tel dispositif et procedes pour sa fabrication |
| US7396689B2 (en) * | 2005-02-04 | 2008-07-08 | Decision Biomarkers Incorporated | Method of adjusting the working range of a multi-analyte assay |
| US8445293B2 (en) | 2005-02-09 | 2013-05-21 | Rapid Pathogen Screening, Inc. | Method to increase specificity and/or accuracy of lateral flow immunoassays |
| EP1712914A1 (fr) * | 2005-04-14 | 2006-10-18 | Unisensor S.A. | Procédé in vitro pour la detection et l'identification simultanées d'antibiotiques de classes differentes et trousse de diagnostic correspondante |
| EP1787699A1 (en) * | 2005-11-17 | 2007-05-23 | Vicam, L.P. | Multi-analyte affinity column |
| KR100722321B1 (ko) | 2005-12-28 | 2007-05-28 | 성균관대학교산학협력단 | 모세관력 리소그래피와 자기조립단분자막을 이용한 단백질패턴 형성 방법 및 이를 이용하여 제조된 단백질칩 |
| US8084765B2 (en) * | 2007-05-07 | 2011-12-27 | Xerox Corporation | Electronic device having a dielectric layer |
| WO2009020682A2 (en) | 2007-05-08 | 2009-02-12 | The Trustees Of Boston University | Chemical functionalization of solid-state nanopores and nanopore arrays and applications thereof |
| JP5255247B2 (ja) * | 2007-09-04 | 2013-08-07 | 富士フイルム株式会社 | 基質の結合と反応生成物を同時に検出できるバイオセンサー |
| US20110058984A1 (en) | 2008-05-08 | 2011-03-10 | Hitachi High-Technologies Corporation | Automatic analyzer |
| CN102124096B (zh) | 2008-07-16 | 2014-10-22 | 儿童医疗中心有限公司 | 具有微通道的器官模仿装置及其使用和制造方法 |
| ES2572377T3 (es) | 2009-07-29 | 2016-05-31 | Randox Laboratories Ltd | Método para la detección de la presencia, o el riesgo, de cáncer de vejiga |
| WO2011040996A1 (en) | 2009-09-30 | 2011-04-07 | Quantapore, Inc. | Ultrafast sequencing of biological polymers using a labeled nanopore |
| US20140199764A1 (en) * | 2011-05-09 | 2014-07-17 | President And Fellows Of Harvard College | Microfluidic module and uses thereof |
| US9566560B2 (en) * | 2011-10-06 | 2017-02-14 | Illumina, Inc. | Array domains having rotated patterns |
| US9725687B2 (en) | 2011-12-09 | 2017-08-08 | President And Fellows Of Harvard College | Integrated human organ-on-chip microphysiological systems |
| GB201214440D0 (en) | 2012-08-13 | 2012-09-26 | Randox Lab Ltd | Kidney disease biomarker |
| US20140072959A1 (en) | 2012-09-12 | 2014-03-13 | Force Diagnostics, Inc. | Rapid tests for insurance underwriting |
| GB201218570D0 (en) | 2012-10-16 | 2012-11-28 | Randox Lab Ltd | Method |
| US9651539B2 (en) | 2012-10-28 | 2017-05-16 | Quantapore, Inc. | Reducing background fluorescence in MEMS materials by low energy ion beam treatment |
| US9862997B2 (en) | 2013-05-24 | 2018-01-09 | Quantapore, Inc. | Nanopore-based nucleic acid analysis with mixed FRET detection |
| BE1022360B1 (fr) * | 2013-11-19 | 2016-03-24 | Tekinvest Sprl | Puits de microplaque, support de maintien et procede pour la detection d'analytes |
| US10288618B2 (en) * | 2014-04-09 | 2019-05-14 | Randox Laboratories Ltd. | Diagnosis of cancer by detecting dimeric IL-18 |
| WO2015161219A1 (en) * | 2014-04-17 | 2015-10-22 | SFC Fluidics, Inc. | Microdialysis platform |
| ES2686736T3 (es) | 2014-07-01 | 2018-10-19 | Randox Laboratories Ltd. | Combinaciones de biomarcadores para su uso en la detección del cáncer de páncreas |
| ES2789000T3 (es) | 2014-10-10 | 2020-10-23 | Quantapore Inc | Análisis de polinucleótidos basado en nanoporos con marcadores fluorescentes que se inactivan mutuamente |
| JP6757316B2 (ja) | 2014-10-24 | 2020-09-16 | クアンタポール， インコーポレイテッド | ナノ構造のアレイを使用するポリマーの効率的光学分析 |
| CN112881728B (zh) | 2015-07-15 | 2024-08-06 | Hycor生物医学有限责任公司 | 可定制仪器 |
| GB201519142D0 (en) | 2015-10-29 | 2015-12-16 | Randox Lab Ltd | Method |
| GB201520341D0 (en) * | 2015-11-18 | 2015-12-30 | Randox Lab Ltd And Randox Teoranta | Improvements relating to substrates for the attachment of molecules |
| WO2018002362A1 (en) | 2016-06-30 | 2018-01-04 | Randox Laboratories Ltd | Measurement of fabp for diagnosis |
| US10823721B2 (en) | 2016-07-05 | 2020-11-03 | Quantapore, Inc. | Optically based nanopore sequencing |
| GB201818744D0 (en) | 2018-11-16 | 2019-01-02 | Randox Laboratories Ltd | Detection of bladder cancer |
| GB201910730D0 (en) | 2019-07-26 | 2019-09-11 | Randox Teoranta | Bovine Pathogen Array |
| GB201916186D0 (en) | 2019-11-07 | 2019-12-25 | Randox Laboratories Ltd | Biomarkers for aiding in the diagnosis of mental disorders |
| GB202014755D0 (en) | 2020-09-18 | 2020-11-04 | Randox Laboratories Ltd | Methods to determine coronavirus infectivty status |
| GB202019663D0 (en) | 2020-12-14 | 2021-01-27 | Randox Laboratories | Predictive biomarkers for risk of bladder cancer in diabetes patients |
| GB202104287D0 (en) | 2021-03-26 | 2021-05-12 | Randox Laboratories | Method for determining prognosis of chronic kidney disease |
| GB202111635D0 (en) | 2021-08-13 | 2021-09-29 | Randox Laboratories | Risk prediction model for prostate cancer |
| GB202114088D0 (en) | 2021-10-01 | 2021-11-17 | Randox Laboratories | Detection of bladder cancer in males |
| GB202203639D0 (en) | 2022-03-16 | 2022-04-27 | Randox Laboratories Ltd | Standardisation method for glycosylation arrays |
| GB202204413D0 (en) | 2022-03-29 | 2022-05-11 | Randox Laboratories Ltd | Markers for progression of inflammatory liver disease |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR231590A1 (es) * | 1981-04-29 | 1984-12-28 | Ciba Geigy Ag | Dispositivo de analisis inmunologico y procedimiento para obtenerlo |
| SE431620B (sv) | 1982-07-07 | 1984-02-20 | Stojan Popovic | Suganordning, speciellt avsedd att anvendas som tennsug vid lodningsarbeten |
| US4591570A (en) * | 1983-02-02 | 1986-05-27 | Centocor, Inc. | Matrix of antibody-coated spots for determination of antigens |
| GB8314523D0 (en) * | 1983-05-25 | 1983-06-29 | Lowe C R | Diagnostic device |
| US4745075A (en) * | 1984-09-06 | 1988-05-17 | Burroughs Wellcome Co. | Diagnostic test methods |
| US4829010A (en) * | 1987-03-13 | 1989-05-09 | Tanox Biosystems, Inc. | Immunoassay device enclosing matrixes of antibody spots for cell determinations |
| GB8803000D0 (en) * | 1988-02-10 | 1988-03-09 | Ekins Roger Philip | Determination of ambient concentrations of several analytes |
| SU1696399A1 (ru) | 1988-07-01 | 1991-12-07 | Государственный научно-исследовательский и проектный институт по обогащению руд цветных металлов "Казмеханобр" | Способ очистки сточных вод от ионов т желых металлов |
| WO1990001564A1 (en) * | 1988-08-09 | 1990-02-22 | Microprobe Corporation | Methods for multiple target analyses through nucleic acid hybridization |
| US5077210A (en) * | 1989-01-13 | 1991-12-31 | Eigler Frances S | Immobilization of active agents on substrates with a silane and heterobifunctional crosslinking agent |
| US5120662A (en) * | 1989-05-09 | 1992-06-09 | Abbott Laboratories | Multilayer solid phase immunoassay support and method of use |
| US5474796A (en) * | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
| FR2693740B1 (fr) | 1992-07-17 | 1994-10-14 | Univ Joseph Fourier | Procédé de détection tissulaire ou cellulaire mettant en Óoeuvre des réactifs chimiluminescents. |
| DE69332454T2 (de) | 1992-08-03 | 2003-03-20 | Marconi Optical Components Ltd., London | Trennverfahren |
| JPH06148188A (ja) * | 1992-11-13 | 1994-05-27 | Olympus Optical Co Ltd | 免疫学的再検査方法 |
| EP0692096A1 (en) * | 1993-03-30 | 1996-01-17 | Terrapin Technologies, Inc. | Determination of concentration by affinity titration and competitive displacement in drug delivery |
| EP0700514B1 (en) * | 1993-05-18 | 2001-11-28 | University of Utah Research Foundation | Apparatus and methods for multianalyte homogeneous fluoroimmunoassays |
| GB9325100D0 (en) * | 1993-12-07 | 1994-02-02 | Univ Court Of The University O | Device |
| US5814565A (en) * | 1995-02-23 | 1998-09-29 | University Of Utah Research Foundation | Integrated optic waveguide immunosensor |
| US5624711A (en) * | 1995-04-27 | 1997-04-29 | Affymax Technologies, N.V. | Derivatization of solid supports and methods for oligomer synthesis |
| EP0768530A1 (en) * | 1995-10-16 | 1997-04-16 | Nippon Paint Co., Ltd. | Process for assaying biological substance |
| BR9800655A (pt) * | 1997-04-21 | 1999-08-10 | Randox Lab Ltd | Dispositivo de estado sólido para efetuar ensaios com múltiplos analisados seu uso e e sistema para análise de múltiplos analisados |
| EP0874242B2 (en) * | 1997-04-21 | 2009-06-03 | Randox Laboratories Ltd. | Device and apparatus for the simultaneous detection of multiple analytes |
-
1998
- 1998-04-17 BR BR9800655A patent/BR9800655A/pt not_active Application Discontinuation
- 1998-04-17 CZ CZ0116998A patent/CZ297165B6/cs not_active IP Right Cessation
- 1998-04-20 AU AU61988/98A patent/AU713388B2/en not_active Expired
- 1998-04-20 NO NO981766A patent/NO981766L/no not_active Application Discontinuation
- 1998-04-20 DE DE69829089T patent/DE69829089T3/de not_active Expired - Lifetime
- 1998-04-20 NZ NZ330227A patent/NZ330227A/en not_active IP Right Cessation
- 1998-04-20 PT PT98303019T patent/PT874242E/pt unknown
- 1998-04-20 HU HU9800920A patent/HU220777B1/hu not_active IP Right Cessation
- 1998-04-20 CA CA002235183A patent/CA2235183C/en not_active Expired - Lifetime
- 1998-04-20 RU RU98107571/13A patent/RU2168174C2/ru not_active IP Right Cessation
- 1998-04-20 UA UA98041977A patent/UA54400C2/uk unknown
- 1998-04-20 AT AT98303019T patent/ATE289684T1/de not_active IP Right Cessation
- 1998-04-20 ES ES98303019T patent/ES2238750T5/es not_active Expired - Lifetime
- 1998-04-20 SG SG9800759A patent/SG87765A1/en unknown
- 1998-04-20 GB GB9808309A patent/GB2324866B/en not_active Expired - Lifetime
- 1998-04-21 PL PL98325914A patent/PL325914A1/xx not_active IP Right Cessation
- 1998-04-21 KR KR1019980014131A patent/KR100585548B1/ko not_active IP Right Cessation
- 1998-04-21 AR ARP980101840A patent/AR015110A1/es active IP Right Grant
- 1998-04-21 YU YU17498A patent/YU49328B/sh unknown
- 1998-04-21 SK SK510-98A patent/SK283340B6/sk unknown
- 1998-04-21 TW TW087106047A patent/TWI225928B/zh not_active IP Right Cessation
- 1998-04-21 JP JP11068798A patent/JP4209494B2/ja not_active Expired - Lifetime
- 1998-04-21 CN CNB981152546A patent/CN1178063C/zh not_active Expired - Fee Related
- 1998-04-21 HR HR97302707.1A patent/HRP980215A2/hr not_active Application Discontinuation
- 1998-04-21 ZA ZA983345A patent/ZA983345B/xx unknown
- 1998-04-21 ID IDP980597A patent/ID20179A/id unknown
- 1998-04-21 GE GEAP19984247A patent/GEP20022846B/en unknown
- 1998-04-21 TR TR1998/00737A patent/TR199800737A1/xx unknown
- 1998-04-21 EG EG34198D patent/EG22471A/xx active
- 1998-04-21 MY MYPI98001772A patent/MY114814A/en unknown
- 1998-12-16 HK HK98113653A patent/HK1012202A1/xx not_active IP Right Cessation
-
1999
- 1999-10-07 US US09/413,799 patent/US6498010B1/en not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020157526A1 (en) | 2019-01-28 | 2020-08-06 | Ioi Auranae Kft | Device and method for the automatic determination of anion and cation levels from urine |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU220777B1 (hu) | Több anyag szimultán elemzésére szolgáló eszközök és berendezések | |
| EP0874242B1 (en) | Device and apparatus for the simultaneous detection of multiple analytes | |
| CN100386627C (zh) | 过滤型蛋白芯片 | |
| EP2541248B1 (en) | Preparation method of antigen-immobilized immunofluorescence slide, and immunofluorescence slide prepared thereby | |
| US4689310A (en) | Methods for attaching ligands or anti-ligands to a solid phase | |
| JPH03506078A (ja) | 化学的試験方法において使用する装置 | |
| US7947461B2 (en) | Colloidal silica particle containing light-absorbing substance, nano light-absorbing material, absorption labeling nanobead kit, and method for detection or quantification of biological molecule using the colloidal silica particle containing light-absorbing substance | |
| US4791069A (en) | Methods for attaching ligands or anti-ligands to a solid phase | |
| KR20230121123A (ko) | 분석물 검출방법 | |
| JP2002530661A (ja) | 光学分析用の改善された感度を有するマルチウェルアセンブリ | |
| AU1364300A (en) | Quantitative determination of analytes in a heterogeneous system | |
| JP2000065832A (ja) | フィルター状生物学的特異反応測定用担体およびそれを用いた測定方法 | |
| EP0483309A1 (en) | Solid support having antibodies immobilized thereon | |
| JP2014062814A (ja) | 抗原固定化免疫蛍光スライドの製造方法及びそれにより製造される免疫蛍光スライド | |
| MXPA98003102A (es) | Dispositivo y aparato para la deteccion simultanea de analitos multiples | |
| US20100021930A1 (en) | Application of surface plasmon resonance technology to maternal serum screening for congenital birth defects | |
| WO2006041392A1 (en) | Preparation and use of a reactive solid support surface | |
| Burdick | Evanescent-wave biosensors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of definitive patent protection due to non-payment of fees |